- Home
- ATON vs QNRX Comparison
ATON vs QNRX Comparison
Compare ATON & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATON | QNRX |
|---|---|---|
| Founded | 1973 | 2018 |
| Country | British Virgin Islands | United States |
| Employees | 4 | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 10.7M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | ATON | QNRX |
|---|---|---|
| Price | $0.33 | $6.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 22.3K |
| Earning Date | 07-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.28 | $5.20 |
| 52 Week High | $13.80 | $41.80 |
Technical Indicators
Market Signals| Indicator | ATON | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 47.86 |
| Support Level | $0.28 | $5.34 |
| Resistance Level | $0.35 | $6.98 |
| Average True Range (ATR) | 0.03 | 0.49 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 71.54 | 69.80 |
Price Performance
Historical ComparisonAbout ATON AlphaTON Capital Corp.
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.